International Journal of Hematology

, Volume 85, Issue 5, pp 430–436 | Cite as

Interphase Fluorescence In Situ Hybridization Detection of Cytogenetic Abnormalities in B-Cell Chronic Lymphocytic Leukemia

  • Wei Xu
  • Jian-Yong Li
  • Jin-Lan Pan
  • Hai-Rong Qiu
  • Yun-Feng Shen
  • Li Li
  • Ya-Fang Wu
  • Yong-Quan Xue
Article

Abstract

The most frequent chromosomal abnormalities in B-cell chronic lymphocytic leukemia (B-CLL) are deletions on 13q14 and 17p13, trisomy 12, and 14q32 rearrangement. Conventional cytogenetic analysis underestimates the frequency of specific chromosome aberrations in B-CLL because of the low rate of spontaneous mitoses and the poor response to mitogen stimulation. We used interphase fluorescence in situ hybridization (I-FISH) to explore the incidence of chromosomal changes in the peripheral blood cells of B-CLL patients. Probes for 13q14 (D13S319), 17p13 (p53), the centromere of chromosome 12 (CEP12), and 14q32 (IGHC/IGHV) were applied to detect chromosomal aberrations in peripheral blood samples from 83 B-CLL patients (60 men, 23 women). Molecular cytogenetic aberrations were found in 61 cases (73.5%), and 8 patients (9.6%) showed 2 kinds of abnormalities. The most frequent abnormality was deletion of 13q14 (41.0%), followed by +12 (19.3%), deletion of 17p13 (12%), and 14q32 rearrangement (9.6%). FISH results were analyzed for correlation with Binet stages. The percentages of patients who showed abnormalities by FISH were 73.0%, 73.3%, and 80% for Binet stages A, B, and C, respectively, and the percentages of patients with abnormalities who showed 2 anomalies were 7.9%, 27.3%, and 0% for Binet stages A, B, and C, respectively. We noted no consistent pattern among the various Binet stages in the distribution of either the types of FISH-detected anomalies or the numbers of FISH anomalies. I-FISH was found to be a rapid, exact, and sensitive technique for analysis of chromosome aberrations in CLL. FISH could provide accurate information regarding the molecular cytogenetic features of CLL.

Key words

Chronic lymphocytic leukemia Fluorescence in situ hybridization Chromosome 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Muller-Hermelink HK, Montserrat E, Catovsky D, Harris NL. Chronic lymphocytic leukaemia/small lymphocytic lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours. Pathology & Genetics: Tumours of the Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:127–130.Google Scholar
  2. 2.
    Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood. 1975;46:219–234.Google Scholar
  3. 3.
    Binet JL, Lepoprier M, Dighiero G, et al. A clinical staging system for chronic lymphocytic leukemia: prognostic significance. Cancer. 1977;40:855–864.CrossRefGoogle Scholar
  4. 4.
    Juliusson G, Oscier DG, Fitchett M, et al. Prognostic subgroups in B-cell chronic lymphocyte leukemia defined by specific chromosomal abnormalities. N Engl J Med. 1990;323:720–724.CrossRefGoogle Scholar
  5. 5.
    Dohner H, Stilgenbauer S, Dohner K, Bentz M, Lichter P. Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis. J Mol Med. 1999;77:266–281.CrossRefGoogle Scholar
  6. 6.
    Goorha S, Glenn MJ, Drozd-Borysiuk E, Chen Z. A set of commercially available fluorescent in-situ hybridization probes efficiently detects cytogenetic abnormalities in patients with chronic lymphocytic leukemia. Genet Med. 2004;6:48–53.CrossRefGoogle Scholar
  7. 7.
    Dohner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000;343:1910–1916.CrossRefGoogle Scholar
  8. 8.
    Bentz M, Huck K, du Manoir S, et al. Comparative genomic hybridization in chronic B-cell leukemias shows a high incidence of chromosomal gains and losses. Blood. 1995;85:3610–3618.Google Scholar
  9. 9.
    Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias: French-American-British (FAB) Cooperative Group. J Clin Pathol. 1989;42:567–584.CrossRefPubMedGoogle Scholar
  10. 10.
    Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361–1392.Google Scholar
  11. 11.
    Dewald GW, Brockman SR, Paternoster SF, et al. Chromosome anomalies detected by interphase fluorescence in situ hybridiza- tion: correlation with significant biological features of B-cell chronic lymphocytic leukaemia. Br J Haematol. 2003;121:287–295.CrossRefGoogle Scholar
  12. 12.
    Escudier SM, Pereira-Leahy JM, Drach JW, et al. Fluorescent in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemia. Blood. 1993;81:2702–2707.Google Scholar
  13. 13.
    Juliusson G, Merup M. Cytogenetics in chronic lymphocytic leukemia. Semin Oncol. 1998;25:19–26.Google Scholar
  14. 14.
    Criel A, Verhoef G, Vlietinck R, et al. Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases. Br J Haematol. 1997;97:383–391.CrossRefGoogle Scholar
  15. 15.
    Geisler CH, Philip P, Christensen BE, et al. In B-cell chronic lymphocytic leukaemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis: a cytogenetic and immunophenotypic study of 480 unselected newly diagnosed patients. Leuk Res. 1997;21:1011–1023.CrossRefGoogle Scholar
  16. 16.
    Mould S, Gardiner A, Corcoran M, Oscier DG. Trisomy 12 and structural abnormalities of 13q14 occurring in the same clone in chronic lymphocytic leukaemia. Br J Haematol. 1996;92:389–392.CrossRefGoogle Scholar
  17. 17.
    Mayr C, Speicher MR, Kofler DM, et al. Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia. Blood. 2006;107:742–751.CrossRefGoogle Scholar
  18. 18.
    Gozzetti A, Le Beau MM. Fluorescence in situ hybridization: uses and limitations. Semin Hematol. 2000;37:320–333.CrossRefGoogle Scholar
  19. 19.
    Hogan WJ, Tefferi A, Borell TJ, Jenkins R, Li CY, Witzig TE. Prognostic relevance of monosomy at the 13q14 locus detected by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet. 1999;110:77–81.CrossRefGoogle Scholar
  20. 20.
    Dohner H, Fischer K, Bentz M, et al. p53 gene deletion predicts for poor survival and non-response to therapy with purine analogues in chronic B-cell leukaemias. Blood. 1995;85:1580–1589.Google Scholar
  21. 21.
    Stilgenbauer S, Dohner H. Molecular genetics and its clinical relevance. Hematol Oncol Clin North Am. 2004;18:827–848.CrossRefGoogle Scholar
  22. 22.
    Dyer MJ, Oscier DG. The configuration of the immunoglobulin genes in B cell chronic lymphocytic leukemia. Leukemia. 2002;16:973–984.CrossRefGoogle Scholar
  23. 23.
    Stilgenbauer S, Bullinger L, Lichter P, Dohner H, and the German CLL Study Group (GCLLSG). Genetics of chronic lymphocytic leukemia: genomic aberrations and V H gene mutation status in pathogenesis and clinical course. Leukemia. 2002;16:993–1007.CrossRefGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2007

Authors and Affiliations

  • Wei Xu
    • 1
  • Jian-Yong Li
    • 1
  • Jin-Lan Pan
    • 2
  • Hai-Rong Qiu
    • 1
  • Yun-Feng Shen
    • 3
  • Li Li
    • 1
  • Ya-Fang Wu
    • 2
  • Yong-Quan Xue
    • 2
  1. 1.Department of Hematology1st Affiliated Hospital of Nanjing Medical University, Jiangsu Province HospitalNanjingChina
  2. 2.Jiangsu Institute of Hematology1st Affiliated Hospital of Soochow UniversitySuzhouChina
  3. 3.Department of Hematology1st Hospital of WuxiWuxiChina

Personalised recommendations